Effect of preventing coronary artery disease multimedia software on adjusting risk factors in patients with heart disease

Phase 2

• Conditions: Diseases of arteries, arterioles and capillaries; Coronary Artery Disease.

• Registration Number: IRCT2017072220833N3
• Lead Sponsor: Vice chancellor for research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Acute Coronary Syndrome(acute myocardial infarction with elevated ST segment, myocardial infarction without ST elevation and unstable angina); having computer at home; willingness for participating in the study; being oriented of their disease; knowing Persian language; not having mental retardation, disabilities, blindness, Deafness and active psychological disease; not having thyroid and digestive disease; not having complications of acute coronary syndrome like acute pulmonary edema and congestive heart disease.
Exclusion criteria: unwillingness for participating in the study and filling questionnaires incompletely.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: before the intervention and three month after the intervention. Method of measurement: Mercury barometric.;Blood Triglyceride. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Low-density lipoprotein(LDL). Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;High-density lipoprotein(HDL). Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Cholesterol. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.;Fasting blood sugar. Timepoint: before the intervention and three month after the intervention. Method of measurement: Spectrophotmetery.